Puls Biznesu: Funding needed for dog medications. Bioceltix seeks capital again

Dr. Paweł Wielgus, Eng., spoke with Puls Biznesu about current plans to raise capital for the construction of a new plant and summarized the company’s current developments. “We are working on responses to EMA inquiries; the deadline for submitting them is the end of the year. We are re-validating the technological route, and an inspection […]

Telewizja Biznesowa: Bioceltix – from a startup to a million-dollar company

During the Wall Street in Karpacz, Dr. Paweł Wielgus, Eng., spoke with Telewizja Biznesowa about our journey from idea to commercialization. We went back a decade to reminisce about our first PowerPoint presentation and the determination with which we convinced investors that veterinary medicine deserved a breakthrough, and that we had a plan for it. […]

Parkiet.com: Pessimism around biotechnology is absurdly high. Will the tide turn?

This is an important time for Polish biotechnology. Despite geopolitical turmoil, many companies are increasingly close to breakthroughs and commercialization of their projects. We believe that the successful registration process of BCX-CM-J for canine osteoarthritis and BCX-EM for equine arthritis will pave the way for further innovations from Poland. Meanwhile, significant biotechnology projects typically originate […]

Gazeta Wyborcza: Veterinary Medicine. The largest stem cell factory will be created in Wrocław.

Veterinary biotechnology has the potential to revolutionize the current approach to animal treatment, increasing effectiveness and reducing side effects, says Dr. Paweł Wielgus, Eng., in a new interview with Gazeta Wyborcza. We discuss plans related to, among other things, the new plant with representatives of the Wałbrzych Special Economic Zone “Invest-Park,” as our new facility […]

Puls Biznesu: Dog medicines are heating up Bioceltix

Dog medications are heating up Bioceltix, we read in Puls Biznesu. The same goes for the results of this year’s “Listed Company of the Year,” as we mark the 26-year history of the ranking as: Leader in the Success category in 2024, Leader in the Development Prospects category, and 3rd place overall (tied with Vercom […]

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.